[Pulmonary hemodynamics in acute and chronic inflammatory lung diseases in children]

Meditsinskaia Radiologiia
|June 1, 1988
PubMed

Insights

This study reveals how blood flow changes in children with acute and chronic lung inflammation. Acute pneumonia involves reduced blood vessel networks, while chronic conditions show decreased blood flow and oxygen in affected lung areas.

Area of Science:

  • Pediatric Pulmonology
  • Cardiovascular Physiology
  • Medical Imaging

Background:

  • Pulmonary inflammatory diseases in children can significantly impact hemodynamics.
  • Understanding the specific circulatory changes is crucial for effective treatment.
  • Acute and chronic lung conditions present distinct pathophysiological mechanisms.

Purpose of the Study:

  • To investigate pulmonary hemodynamic alterations in pediatric patients with acute and chronic inflammatory lung diseases.
  • To elucidate the angiological mechanisms underlying these conditions.
  • To differentiate circulatory changes between acute suppurative-destructive pneumonia and chronic nonspecific pulmonary inflammatory diseases.

Main Methods:

  • Radionuclide diagnostics
  • Angiography
  • Hemodynamic assessments in 155 pediatric patients (1 month to 15 years)
  • Comparative analysis of acute and chronic inflammatory lung disease patterns

Main Results:

  • Acute suppurative-destructive pneumonia pathogenesis involves a reduced pulmonary microcirculatory network and regional blood flow redistribution.
  • Chronic nonspecific pulmonary inflammatory diseases exhibit regional hypoperfusion, decreased blood oxygen saturation, and reduced blood flow volumes.
  • Regional arterial pulmonary hypertension was observed in chronic inflammatory lung diseases.

Conclusions:

  • Pulmonary hemodynamics are significantly altered in pediatric inflammatory lung diseases.
  • Distinct angiological mechanisms differentiate acute and chronic inflammatory pulmonary conditions.
  • These findings aid in understanding disease progression and guiding therapeutic strategies.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...